[Featured Stock] Zetema Obtains Patent for Commercialization of Lipolysis Injection
[Asia Economy Reporter Hyungsoo Park] Zetema is showing strong performance. The news of obtaining a patent related to 'local injection composition' appears to have influenced the stock price.
As of 2:59 PM on the 15th, Zetema is trading at 24,800 KRW, up 2.48% from the previous day.
Zetema introduced that the fat-dissolving injection is a freeze-dried dry powder formulation with excellent storage stability. They explained that since the pH is below 8.2, when dissolved in injection water, it creates a pH environment closer to the human body compared to conventional injections, resulting in less injection pain. They emphasized that DCA does not precipitate and dissolves well in injection water.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Zetema stated that they will commercialize the fat-dissolving injection using the patent.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
